Elligo Health Research
PrivateLast Round
Debt
Oct 2, 2023
Total Funding Raised
$216.75M
Company Overview
Elligo Health Research is a healthcare-enabling research organization that provides clinical trial recruitment, infrastructure, and technology solutions to accelerate the development of pharmaceutical, biotechnology, and medical device products.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Patient Engagement, Healthcare Analytics, Vertical SaaS
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elligo Health Research Comparables
Compare Elligo Health Research with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Circuit Clinical | 88% | |
| Innovo Research | 86% | |
| Care Access | 85% |
Elligo Health Research Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Oct 2, 2023 | ||||
| Series E | Sep 23, 2021 | ||||
| Series D | Dec 8, 2020 | ||||
| Grant | Oct 1, 2019 | ||||
| Series C | May 7, 2019 | ||||
Series B | Mar 20, 2018 |
Elligo Health Research Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Morgan Stanley Expansion Capital | Series E |
| Ally Bridge Group | Series E |
| Hatteras Venture Partners | Series E, Series C, Series A, Series B |
| Norwest Venture Partners | Series E |
| Noro-Moseley Partners | Series E, Series C, Series A, Series B |
| Shumway Capital | Series E, Series A, Series B |
| Horizon Technology Finance Corporation | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 23, 2021
$135M round led by Ally Bridge Group and Morgan Stanley.
- Dec 8, 2020
Raised Series D led by Oracle Corporation.
Elligo Health Research Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Elligo Health Research's valuation, stock price, and market status.
Is Elligo Health Research a public or private company?
Elligo Health Research is a private company.
What is the current stock price of Elligo Health Research?
Elligo Health Research is a private company with no public stock price. No recent secondary market data is available.
How much is Elligo Health Research worth (valuation)?
Valuation information for Elligo Health Research is not publicly available.
Can I buy Elligo Health Research stock?
Elligo Health Research shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Elligo Health Research's last funding round?
Elligo Health Research's most recent funding round was Debt on October 2, 2023.
Who are the main investors in Elligo Health Research?
Key investors in Elligo Health Research include Morgan Stanley Expansion Capital, Ally Bridge Group, Hatteras Venture Partners, Noro-Moseley Partners, Horizon Technology Finance Corporation.
Will Elligo Health Research IPO soon?
No public IPO plans have been announced for Elligo Health Research.
How can I track Elligo Health Research secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Elligo Health Research's secondary market activity and sign up for updates.